These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 791566)

  • 41. [Controlled clinical evaluation of cicloxilic acid in hepatopathies caused by psychopharmacological agents].
    Bocci U; Beretta G
    Clin Ter; 1980 May; 93(4):373-88. PubMed ID: 6998639
    [No Abstract]   [Full Text] [Related]  

  • 42. [Effect of cholagogic agents on volumetric natriuresis in rats with experimental dystrophy of the liver].
    Iakovlev VE
    Farmakol Toksikol; 1978; 41(1):73-6. PubMed ID: 624393
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Experiences with Vitamin B-12 therapy of chronic liver diseases in a resort practice].
    André W
    Munch Med Wochenschr; 1966 Mar; 108(11):610-1. PubMed ID: 6013869
    [No Abstract]   [Full Text] [Related]  

  • 44. [Current status of hepatic and biliary drug therapy. II].
    Donatelli L; Marmo E
    Clin Ter; 1976 Mar; 76(6):495-513. PubMed ID: 797505
    [No Abstract]   [Full Text] [Related]  

  • 45. [Effect of galascorbin in respiration and oxidative phosphorylation of mitochondria of liver affected by carbon tetrachloride poisoning].
    Shampaĭ EF; Kokarovtseva MG
    Ukr Biokhim Zh; 1967; 39(6):645-8. PubMed ID: 5603177
    [No Abstract]   [Full Text] [Related]  

  • 46. Mechanism of carbon tetrachloride hepatotoxicity. An in vivo study of its molecular basis in rats and monkeys.
    Chopra P; Roy S; Ramalingaswami V; Nayak NC
    Lab Invest; 1972 Jun; 26(6):716-27. PubMed ID: 4402320
    [No Abstract]   [Full Text] [Related]  

  • 47. [Use of a new synthetic cholerectic agent in the therapy of some gastro-duodeno-biliary and pancreatic diseases].
    Azzena D
    Clin Ter; 1972 Apr; 61(1):47-58. PubMed ID: 5039601
    [No Abstract]   [Full Text] [Related]  

  • 48. [The choleretics].
    Geoffroy H; Dezoteux H
    Maroc Med; 1967 Jul; 47(504):506-11. PubMed ID: 5613355
    [No Abstract]   [Full Text] [Related]  

  • 49. [The pharmacological properties of the triterpenoids from birch bark].
    Vasilenko IuK; Semenchenko VF; Frolova LM; Konopleva GE; Parfent'eva EP; Skul'te IV
    Eksp Klin Farmakol; 1993; 56(4):53-5. PubMed ID: 8220020
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Use of cholagogic agents in the therapy of patients with dysfunction of the bile-secreting system].
    Nogaller AM; Barkhanova AG; Zakharova GIu
    Klin Med (Mosk); 1989 Sep; 67(9):129-35. PubMed ID: 2685457
    [No Abstract]   [Full Text] [Related]  

  • 51. [Experimental results and therapeutic activity of a protein-free hepatic extract in cases of hepatobiliary disorders of surgical importance].
    Boselli G
    Minerva Med; 1967 Oct; 58(87):3725-33. PubMed ID: 6075228
    [No Abstract]   [Full Text] [Related]  

  • 52. [Indications and contraindications of choleretic therapy].
    Grossi F
    Clin Ter; 1974; 70(2):108-9. PubMed ID: 4409826
    [No Abstract]   [Full Text] [Related]  

  • 53. [Studies of the choleretic and liver-protective effects of the product, "Menabil Complex"].
    Gheorghescu B; Steflea D; Jovin G; Suseanu I
    Fiziol Norm Patol; 1973; 19(1):51-6. PubMed ID: 4266192
    [No Abstract]   [Full Text] [Related]  

  • 54. [Ultrastructural changes in the rat liver under the effect of various choleretics].
    Hegewald G; Bärenwald G; Möritz KU; Grisk A
    Acta Hepatosplenol; 1968; 15(6):382-9. PubMed ID: 5710490
    [No Abstract]   [Full Text] [Related]  

  • 55. [Personal experiences in the treatment of bile duct diseases using Genebil].
    De Marcos Perez VM
    Rev Esp Enferm Apar Dig; 1969 Nov; 29(4):569-84. PubMed ID: 5363141
    [No Abstract]   [Full Text] [Related]  

  • 56. [Choleretics].
    Tagliareni F
    Minerva Nipiol; 1967; 17(4):136-41. PubMed ID: 5620855
    [No Abstract]   [Full Text] [Related]  

  • 57. [Effect of cortisol on the protein synthesizing capacity of a microsomal fraction of the liver of rats given tetrachlormethane].
    Angelov ETs; Rikhter G
    Probl Endokrinol (Mosk); 1972; 18(3):93-6. PubMed ID: 5029296
    [No Abstract]   [Full Text] [Related]  

  • 58. [Change in the osmotic properties of the mitochondria in CCl 4 poisoning].
    Liakhovich VV; Mishin VM; Dolgov AV
    Farmakol Toksikol; 1972 Jul; 35(4):486-8. PubMed ID: 5050285
    [No Abstract]   [Full Text] [Related]  

  • 59. [Effect of galascorbin and pangamic acid on some indices of energy metabolism of mitochondria of livers from rats with experimental toxic hepatitis].
    Shamraĭ EF; Selezneva AK
    Ukr Biokhim Zh; 1969; 41(3):241-5. PubMed ID: 5354668
    [No Abstract]   [Full Text] [Related]  

  • 60. [Study of an hepatic analeptic by enzyme determinations and hepatic clearance tests].
    Boisson J
    Ann Gastroenterol Hepatol (Paris); 1972; 8(2):191-6. PubMed ID: 5056542
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.